Efficient synthesis of CCR5 antagonist, 2,3-dihydro-1-benzothiepine derivatives by improved intramolecular Claisen type reaction using dialkylcarbonate

The efficient synthesis of 2,3-dihydro-1-benzothiepine derivatives 4 has been developed. The intramolecular Claisen type reaction of the new products, 4-(o-formylphenylthio)butyrate 9, with alcoholate in dialkylcarbonate as a solvent afforded 4 in good yields. According to this new procedure, we have accomplished the practical preparation of CCR5 antagonist 1 as a candidate for oral HIV-1 therapy.     

Molecular Spectroscopic Study on the Interaction between Heparin and Neutral Red

The interaction between heparin and neutral red was investigated by molecular spectroscopic methods. The change of all spectra suggested that positively charged neutral red had interacted with negatively charged heparin. The study of influence factors indicated that electrostatic force and hydrophobic bond might be involved in the interaction. The total binding number per disaccharide unit and intrinsic binding constant were obtained using Scatchard model.     

DNA与目标分子相互作用的预测性研究

以量化的分子结构参数和实验结果为依据, 运用模式识别技术、多元线性回归和人工神经网络研究了目标分子与DNA相互作用的主要影响因素, 建立了准确性较高的2个键合常数预测模型和1个作用模式预测模型. 初次量化的分子结构参数有21种, 经过筛选发现其中的10种参数对相互作用有显著影响. 研究结果可为抗癌药物的分子设计和筛选提供有价值的信息.     

钢都酒的香味成分分析

通过对钢都酒进行化学处理,分类收集组分,采用GC-MS联用技术对各组分进行分离与定性定量测定,分离并鉴定出35个化合物,并确定了酒的香型。     

聚中性红膜修饰电极测定痕量NO2^—的研究

研究了聚中性红膜修饰电极对ＮＯ－２的催化氧化性能，建立了测定ＮＯ－２的新方法。ＮＯ－２的浓度在２．０×１０－６～５．０×１０－３ｍｏｌ／Ｌ范围内与催化氧化峰电流呈良好的线性关系，检测限为６．０×１０－７ｍｏｌ／Ｌ。若利用计时电流法分析，检测限可达８．０×１０－８ｍｏｌ／Ｌ。     

Crystallization of chiral compounds. 1. Spectroscopic,thermochemical, and crystallographic investigation of homochiral and racemic glycidyl p-toluenesulfonate

Crystalline specimens of homochiral and racemic glycidyl p-toluenesulfonate were studied by IR spectroscopy, differential scanning calorimetry, and X-ray diffraction analysis. The melting phase diagram of glycidyl p-toluenesulfonate was constructed. The stacking effect in the crystals of the racemic sulfonate is responsible for a more dense molecular packing, with the result that a heterochiral type of crystallization becomes more favorable.     

Evaluation of Orbital- and Ground State Energies of Some Open- and Closed-Shell Atoms over Integer and Noninteger Slater Type Orbitals

Ab initio calculations of the orbital and the ground state energies of some open- and closed-shell atoms over Slater type orbitals with quantum numbers integer and Slater type orbitals with quantum numbers noninteger have been performed. In order to increase the efficiency of these calculations the atomic two-electron integrals were expressed in terms of incomplete beta function. Results were observed to be in good agreement with the literature.     

中性芳烃稀土有机配合物的合成、结构及性能研究——Ⅲ.RE(C_6H_6)(AlCl_4)_3C_6H_6(RE=La,Nd)的合成及Nd(C_6H_6)(AlCl_4)_3C_6H_6的晶体结构

将加热活化的AlCl_3与三氯化稀土在苯溶液中反应,合成了2个新的轻稀土中性芳烃配合物RE(C_6H_6)(AlCl_4)_3C_6H_6(RE=La或Nd)。并用元素分析和红外光谱对其进行了表征。测定了含Nd配合物的晶体结构。对2个配合物结构的比较表明,中心金属离子对配合物的结构无明显影响,其键参数的差别主要来自“镧系收缩”。     

ANN原子参数法预报合金相晶型及晶格常数

运用人工神经网络方法，以二元合金组成元素的电子结构为基本特征，对二元合金相晶型作了区分，进一步对其晶格常数作了预报，结果令人满意。     

Metabolomic-based investigation of Yinlan alleviating hyperlipidemia by inhibiting blood stasis and phlegm turbidity through the PXR-CYP3A4-ABCB1-FXR pathway

Yinlan lipid regulatory capsule (YL) is a composite traditional Chinese medicine (TCM) new drug to alleviate hyperlipidemia, while its therapeutic mechanism in vivo was not clarified with nontargeted metabolomics investigation. An animal model was established in rats fed a high-fat diet, and their body weights, body mass index (BMI) and blood cholesterol levels were measured. Serum, liver and kidney tissue samples were also extracted for PXR-CYP3A4-ABCB1-FXR signaling pathway research using PCR and UHPLC–MS. The obtained plasma samples were analyzed by UHPLC-Q-TOF-MS metabolomic investigation, which revealed PXR-CYP3A4-related metabolites and changes induced by YL. Finally, the key metabolites were chosen as index components, and their levels in the serum, liver, small intestine and bile were used for simultaneous UHPLC–MS-MS determination. The results indicated that YL was effective in rebalancing blood TG and TC levels (compared to controls). With respect to the PXR-CYP3A4-ABCB1 pathway, as a result of YL’s effect, gene expression or activity of the two targets decreased significantly in both the liver and kidney. The same trend was observed in the serum samples mentioned above. Metabolomics screening and data revealed that 44 metabolites can be regarded as biomarkers related to hyperlipidemia, fatty acids synthesis, and body energy consumption, as well as synthesis, transportation and exertion of cholesterol. YL’s treatment focused on 26 of them, primarily bile acids, indicating that the antihyperlipidemic effect of this drug lies in its inhibitory activity of cholesterol metabolism. Subsequent analysis of those in vivo components revealed that significant increases (compared to the model group) occurred in the blood, liver, small intestine and bile in groups that received medium and high doses of YL (while the low dose was relatively unchanged). Those target components exhibit a close relationship with PXR and/or CYP3A4. The use of YL repressed PXR expression and subsequently decreased CYP3A4 activity. As a result, synthesis of related bile acids increased, while cholesterol levels decreased, consequently leading to the attenuation of hyperlipidemia. This study comprehensively investigated the antihyperlipidemia mechanism of YL based on its repression of PXR-CYP3A4 activity and related metabolite yield, establishing an accurate method for evaluating the therapeutic effect of YL.